Nevertheless, LAC injection in tumor effectively liberated IL-12 and IFN-γ and thus elevating downstream chemokines CXCL-9 and CXCL-10, particularly in RNF8 deficient mice (Fig. 6, Supplementary Figs. 6–8). The gene discussed is CXCL9; the disease is neoplasm.